Literature DB >> 17315384

Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells.

Najma Latif1, Padmini Sarathchandra, Penny S Thomas, Joe Antoniw, Puspa Batten, Adrian H Chester, Patricia M Taylor, Magdi H Yacoub.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Human mesenchymal stem cells (MSCs) are a potential cell source for the tissue engineering of biological structures, including cardiac valves. A comprehensive, phenotypic analysis of MSCs and, for the latter, their comparison with valve interstitial cells (ICs) is therefore essential.
METHODS: Isolates of bone marrow-derived human MSCs and human cardiac valve ICs were extensively phenotyped for their expression of membrane proteins involved in adhesion and cell-cell communication, cytoskeletal components, extracellular matrix (ECM) proteins and gene expression of WNT/FZD/SFRP/DKK/LRP family members.
RESULTS: MSCs and valve ICs (>80%) expressed fibroblast surface antigen, smooth muscle alpha-actin, vimentin and CD44; expression of MHC class I and II and calponin was inconsistent, and a small proportion expressed desmin and smooth muscle myosin. CD105 was weakly expressed by a low percentage of valve ICs (<10%) compared to MSCs (>90%). ECM components made by both cell types demonstrated similar levels and patterns of staining, although expression of elastin was not detected by both cell types. Adhesion molecule expression was highly variable among the MSC isolates and between the two cell types, with the predominant integrins being alphal, alpha3, alpha5, and beta1 by both cell types. PCR analysis of WNT/FZD/SFRP/LRP family members revealed a greater range of the WNT family of genes being expressed in MSCs compared to ICs.
CONCLUSION: The study results provided an extensive fingerprint of valve ICs and of MSCs for the tissue engineering of biological structures and for the manipulation of their desired phenotype. MSCs represent a promising cell type for valve tissue engineering, and will require extensive phenotyping after differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17315384

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  19 in total

Review 1.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes.

Authors:  Donal MacGrogan; Guillermo Luxán; Anita Driessen-Mol; Carlijn Bouten; Frank Baaijens; José Luis de la Pompa
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 2.  Heart Valve Replacements with Regenerative Capacity.

Authors:  Petra E Dijkman; Emanuela S Fioretta; Laura Frese; Francesco S Pasqualini; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

3.  Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering.

Authors:  Mary E Tedder; Agneta Simionescu; Joseph Chen; Jun Liao; Dan T Simionescu
Journal:  Tissue Eng Part A       Date:  2010-09-06       Impact factor: 3.845

4.  Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering.

Authors:  Nafiseh Masoumi; Aurélie Jean; Jeffrey T Zugates; Katherine L Johnson; George C Engelmayr
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

5.  Lectin and antibody-based histochemical techniques for cardiovascular tissue engineering.

Authors:  Agneta Simionescu; Mary E Tedder; Ting-Hsien Chuang; Dan T Simionescu
Journal:  J Histotechnol       Date:  2011-03       Impact factor: 0.714

6.  Mitral valve endothelial cells with osteogenic differentiation potential.

Authors:  Jill Wylie-Sears; Elena Aikawa; Robert A Levine; Jeong-Hee Yang; Joyce Bischoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-16       Impact factor: 8.311

7.  Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells.

Authors:  Shirin Masjedi; Ying Lei; Jenny Patel; Zannatul Ferdous
Journal:  Heart Vessels       Date:  2016-10-19       Impact factor: 2.037

8.  Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.

Authors:  Katelynn Toomer; Kimberly Sauls; Diana Fulmer; Lilong Guo; Kelsey Moore; Janiece Glover; Rebecca Stairley; Joyce Bischoff; Robert A Levine; Russell A Norris
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

9.  Fibronectin-based isolation of valve interstitial cell subpopulations: relevance to valve disease.

Authors:  Elizabeth H Stephens; Thanh N Huynh; Jennifer D Cieluch; K Jane Grande-Allen
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

10.  Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering.

Authors:  Dan T Simionescu; Joseph Chen; Michael Jaeggli; Bo Wang; Jun Liao
Journal:  J Healthc Eng       Date:  2012-06       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.